Intézmény
Sixth Affiliated Hospital of Sun Yat-sen University
Más néven: Gastrointestinal and Anal Hospital · Guangdong Gastrointestinal Hospital · Zhongshan Six Hospital · 中山大学附属第六医院
- 134futó vizsgálat
- 33lezárt vizsgálat
- 8053publikáció (OpenAlex)
Futó vizsgálatok
Még nem toboroz
Toboroz
Toboroz
EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer
Toboroz
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma
Toboroz
Toboroz
Még nem toboroz
Még nem toboroz
Még nem toboroz
FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC
Toboroz
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Még nem toboroz
Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Még nem toboroz
Toboroz
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Toboroz
Toboroz
Még nem toboroz
Improvement Effect of Dexamethasone Enema for Acute Radiation-induced Rectal Injury
Toboroz
Toboroz
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
Toboroz
Toboroz
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Toboroz
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Toboroz
Toboroz
Toboroz
TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
Toboroz
Toboroz
Toboroz
Toboroz
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Toboroz
Még nem toboroz
SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer
Toboroz
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
Még nem toboroz
Toboroz
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Toboroz
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Toboroz
Toboroz
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
Toboroz
Epidemiological Characteristics and Efficacy Evaluation of Difficult-To-Treat Crohn's Disease
Toboroz
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Fut, nem toboroz
Toboroz
Még nem toboroz
Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery
Fut, nem toboroz
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Toboroz
Toboroz
Még nem toboroz
Fut, nem toboroz
Toboroz
Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision
Fut, nem toboroz
Toboroz
Toboroz
Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Showing 50 of 134.
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
- Vastagbélrák48 toboroz
- Crohn-betegség21 toboroz
- Gyomor- és nyelőcsőrák14 toboroz
- Colitis ulcerosa13 toboroz
- Fej-nyaki daganatok2 toboroz
- Gyermekkori daganatok2 toboroz
- Tüdőrák2 toboroz
- Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
- Hasnyálmirigyrák1 toboroz
Lezárt vizsgálatok
Visszavonták
Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-
Lezárult
SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer
Toboroz
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Lezárult
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
Lezárult
Lezárult
Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their Spouses
Leállították
Lezárult
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Lezárult
Lezárult
A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Lezárult
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Lezárult
Lezárult
Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
Lezárult
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Leállították
Toboroz
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
Lezárult
Lezárult
Leállították
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Lezárult
Lezárult
Study of Imaginomics Predicting Early Surgical Rates in Crohn's Disease
Lezárult
Lezárult
Lezárult
Lezárult
Lezárult
Lezárult
Lezárult
Lezárult
Recurrence and Bleeding in Colorectal Cancer Patients With Cancer-associated Venous Thrombembolism
Lezárult
Lezárult
Lezárult
Lezárult
Transanal Versus Laparoscopic Total Mesorectal Excision For Rectal Cancer
Regiszterbeli névváltozatok (25)
A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
69 vizsgálat
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, 510655
49 vizsgálat
Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong 510655
19 vizsgálat
Department of colorectal surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong 510000
7 vizsgálat
Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
3 vizsgálat
NCT06858553AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
Contact: Xiang Gao, Professor
NCT05450835OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
Contact: Xinhua Chen, Ph.D
Contact: Jun Huang, M.D.
The Sixth Affiliated Hospital of Sun Yat-sen University (Site 1159)
Guangzhou, Guangdong 510655
2 vizsgálat
Department of Gastroenterology, Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong
1 vizsgálat
NCT05387031Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease
Contact: Min Zhi
Sun yat-sen University, Sixth Affiliated Hospital
Guangzhou, Guangdong 510655
1 vizsgálat
Sun yat-sen University, the Sixth Affiliated Hospital
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University (Site 0828)
Guangzhou, Guangdong 510655
1 vizsgálat
Contact: Study Coordinator
The Sixth Affiliated Hospital of Sun Yat-sen University (Site 3906)
Guangzhou, Guangdong 510655
1 vizsgálat
The Sixth Affiliated Hospital of Sun Yat-sen University (Site 3907)
Guangzhou, Guangdong 526100
1 vizsgálat
Contact: Study Coordinator
Betegségek
Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.
- Vastagbélrák144 munka · 71 vizsgálat
- Crohn-betegség71 munka · 36 vizsgálat
- Colitis ulcerosa36 munka · 32 vizsgálat
- Gyomor- és nyelőcsőrák36 munka · 21 vizsgálat
- Chronic rhinosinusitis with nasal polyps7 munka · 0 vizsgálat
- Female infertility3 munka · 0 vizsgálat
Intézményadatok: ROR 005pe1772 (CC0-1.0)Frissítve: 2026. nov. 15.